The mean number of strongylid eggs/g of feces (EPG) in Group OT (N=5; blue solid bars) and Group IT (N=4; red pattern bars) with standard deviation (SD; vertical error bars) over 42 days post treatment (d.p.t.) presented on logarithmically transformed scale. The missing values on days 28 and 35 represent 0 EPG counts. *Signifi cant reduction in Group OT (P<0.001) and Group IT (P<0.01) as compared to respective groups on day 0.
Fig. 2.
The mean efficacy of moxidectin oral gel in Group OT (N=5; blue line, bold triangles) and injectable moxidectin in Group IT (N=4; red line, bold rectangles) in reducing strongylid egg excretion and 95 % confidence intervals (vertical error bars) over 42 days post treatment (d.p.t.) with the dotted (89.43 %; Group OT) and dashed (89.32 %; Group IT) lines representing threshold set 10 % below the FECT determined at 17 days post-treatment. Significantly higher (*P<0.05; **0.001) as compared to other group on the same time point.